Scientists interrogated clonal hematopoiesis and circulating tumor DNA (ctDNA) in 299 patients with metastatic urothelial or renal cell carcinoma using error-corrected targeted sequencing of matched white blood cell DNA and plasma cfDNA.
[NPJ Precision Oncology]